Advertisement
Advertisement
Trending on Psychiatric Times
1
AI Chatbots and the Erosion of Therapeutic Discomfort
2
VY1706 for Treatment of Alzheimer Disease Shows Tau Reductions and Favorable Tolerability
3
Oral Cannabinoid From MediPharm Shows Significant Reduction in Agitation in Alzheimer Disease and Dementia
4
Podcast: Managing Co-Occurring Mood and Substance Use Disorders With Michael J. Ostacher, MD, MPH
5